Paloma Partners Management Co Makes New Investment in Solventum Co. (NYSE:SOLV)

Paloma Partners Management Co bought a new position in Solventum Co. (NYSE:SOLV) in the 3rd quarter, according to its most recent disclosure with the SEC. The firm bought 13,642 shares of the company’s stock, valued at approximately $951,000.

Other large investors have also recently modified their holdings of the company. Deseret Mutual Benefit Administrators bought a new stake in Solventum during the 2nd quarter valued at approximately $25,000. Hollencrest Capital Management purchased a new stake in Solventum in the second quarter worth $25,000. Richard W. Paul & Associates LLC bought a new position in Solventum in the second quarter worth $26,000. Family Firm Inc. purchased a new position in Solventum during the second quarter valued at $26,000. Finally, Copeland Capital Management LLC bought a new stake in shares of Solventum during the 3rd quarter valued at $26,000.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on the stock. Piper Sandler lifted their price target on shares of Solventum from $71.00 to $75.00 and gave the company a “neutral” rating in a research report on Friday, November 8th. BTIG Research started coverage on Solventum in a research report on Thursday, September 5th. They issued a “neutral” rating on the stock. Morgan Stanley raised their price objective on Solventum from $60.00 to $73.00 and gave the company an “equal weight” rating in a research report on Monday, November 11th. The Goldman Sachs Group increased their target price on Solventum from $48.00 to $54.00 and gave the stock a “sell” rating in a research note on Monday, August 12th. Finally, Wells Fargo & Company reduced their price target on Solventum from $69.00 to $64.00 and set an “equal weight” rating for the company in a report on Friday, August 9th. One analyst has rated the stock with a sell rating, eight have assigned a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $68.00.

Solventum Stock Up 0.6 %

Solventum stock opened at $71.95 on Tuesday. Solventum Co. has a one year low of $47.16 and a one year high of $96.05. The business’s fifty day moving average is $70.55 and its 200 day moving average is $62.58. The company has a quick ratio of 0.83, a current ratio of 1.15 and a debt-to-equity ratio of 2.45.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.